Sign Up

Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.

Have an account? Sign In

Have an account? Sign In Now

Sign In Sign In

Forgot Password?

Don't have account, Sign Up Here

Forgot Password

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.

Have an account? Sign In Now

Please briefly explain why you feel this question should be reported.

Please briefly explain why you feel this answer should be reported.

Please briefly explain why you feel this user should be reported.

Quesra Logo Quesra Logo
Sign InSign Up

Quesra

Quesra Navigation

You can use WP menu builder to build menus
Search
Ask A Question

Mobile menu

Close
Ask a Question
  • Home
  • Blog
  • Contact Us

Quesra Latest Questions

Asked: May 19, 2023

Deep Learning in Drug Discovery market Professional Survey Report by 2035

jameshebrew
jameshebrew Newbie

Read less
  1. jameshebrew Newbie
    Added an answer on May 19, 2023 at 12:14 pm

    In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market.   It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resourcRead more

    In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market.

     

    It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate R&D programs in several domains.

     

    The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:

    • Area of Expertise
    • Cell Therapy
    • Gene Therapy

     

    • Scale of Operation
    • Preclinical
    • Clinical
    • Drug Discovery

     

    • Therapeutic Area
    • Oncological Disorders
    • Neurological Disorders
    • Cardiovascular Disorders
    • Infectious Diseases
    • Metabolic Disorders
    • Autoimmune Disorders
    • Blood Disorders
    • Rare / Genetic Disorders
    • Ophthalmic Disorders
    • Other disorders

     

    • Analysis by Geographical Regions
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and North Africa

     

    The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:

    • Altasciences
    • Charles River Laboratories
    • Creative Biolabs
    • IQVIA
    • Medpace
    • PPD
    • Precision for Medicine
    • Accelera
    • Evotec
    • ICON
    • Syneos Health
    • CMIC Group
    • Labcorp

     

    Table of Contents

     

    1. Preface
    2. Executive Summary

     

    1. Introduction

     

    1. Guide To Outsourcing

     

    1. Market Landscape

     

    1. Company Profiles

     

    1. Competitive Benchmarking

     

    1. Partnerships And Collaborations

     

    1. Mergers and Acquisitions

     

    1. Key Acquisition Targets

     

    1. Likely Partner Analysis for Cell Therapy CROs

     

    1. Likely Partner Analysis for Gene Therapy CROs

     

    1. Clinical Trial Analysis

     

    1. Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations

     

    1. Market Forecast and Opportunity Analysis

     

    1. Swot Analysis

     

    1. Conclusion

     

    1. Interview And Survey Transcripts

     

    1. Appendix 1: Tabulated Data

     

    1. Appendix 2: List of Companies and Organizations

     

    To view more details on this report, click on the link:

    https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html

     

    You may also be interested in the following titles:

    Women’s Digital Health Market
    Modular Manufacturing Facilities Market

     

    You may also like to learn what our experts are sharing in Roots educational series:

    Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?

     

    Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential

     

    About Roots Analysis

    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

     

    Contact:

    Ben Johnson

    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

     

    See less
    • 0
    • Share
      Share
      • Share on Facebook
      • Share on Twitter
      • Share on WhatsApp
      • Report
  • 1 Answer
  • 1 View

Sidebar

About Us

  • Meet The Team
  • Blog
  • Contact Us

Archives

  • December 2021
  • April 2018

Categories

  • Uncategorized
  • Work
WordPress Ads